Abstract

Traditional Chinese medicine is an important component of the health care system in Chinese medical treatment and public health. Rare disease drugs in difficult miscellaneous diseases in traditional Chinese medicine have similar characteristics with the rare disease drugs (orphan drugs) in European and American countries, which both are characterized by individualized medical treatment. The two are different in the development thought. Treatment of difficult miscellaneous diseases in the traditional Chinese medicine is based on the theoretical system of drug incompatibility, whereas orphan drugs in European and American countries lay particular stress on the gene therapy in molecular biology. Adoption of positive incentive policy and excavating folk remedy in the traditional Chinese medicine will promote the market position of the traditional Chinese medicine in the field of international rare disease drugs.

This work is licensed under a Creative Commons Attribution 4.0 License.